3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
10
Neoplasms
5
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Solid Tumors
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Solid Tumor
1
Skin Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Noonan Syndrome
1
Neoplasms, Unknown Primary
1
Neoplasms, Squamous Cell
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Microsatellite Unstable Colorectal Cancer
1
Lung Neoplasms
1
Lung Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
palbociclib
1
olaparib
1
larotrectinib
1
ivosidenib
1
erdafitinib
1
ensartinib
1
X-Rays
1
Vemurafenib
1
Specimen Handling
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
Magnetic Resonance Spectroscopy
1
LY3023414
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Xanthogranuloma, Juvenile
×
cobimetinib
×
Clear all
No trials found.